Ten years ago, the treatment landscape for myositis diseases was, let’s be honest, bleak. We had no FDA-approved treatments for myositis. Only one or two clinical trials were available to…
Continue Reading
New Hope for Those with Myositis
By Theresa Curry Early next year, biopharmaceutical company Priovant Therapeutics, an affiliate of Roivant Sciences, plans to file for FDA approval of brepocitinib. If approved, the drug could become the…
Continue Reading
TMA and MDA Partner to Fund Yale Research on Immune Dysfunction in IBM
Columbia, MD — December 3, 2025 — The Myositis Association (TMA) is proud to announce a new research partnership with the Muscular Dystrophy Association (MDA) to co-fund a groundbreaking study…
Continue Reading
TMA Funding Supports Early Career Researcher
By Begum Horuluoglu, PhD Thanks to the generous support of The Myositis Association (TMA), I have been able to pursue groundbreaking research into the immunological mechanisms underlying idiopathic inflammatory myopathies,…
Continue Reading
Nobel Prize for Autoimmunity Advances Brings Hope to Those with Myositis
This year’s Nobel Prize in Physiology or Medicine was awarded to three scientists—Mary E. Brunkow, Frederick J. Ramsdell, and Shimon Sakaguchi—for discoveries that help explain why the immune system sometimes…
Continue Reading